Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel SARS-CoV-2 Variant Derived from Clade 19B, France.
Fourati S, Decousser JW, Khouider S, N'Debi M, Demontant V, Trawinski E, Gourgeon A, Gangloff C, Destras G, Bal A, Josset L, Soulier A, Costa Y, Gricourt G, Lina B, Lepeule R, Pawlotsky JM, Rodriguez C. Fourati S, et al. Emerg Infect Dis. 2021 May;27(5):1540-1543. doi: 10.3201/eid2705.210324. Emerg Infect Dis. 2021. PMID: 33900195 Free PMC article.
BNT162b2 Messenger RNA Vaccination Did Not Prevent an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 Variant 501Y.V2 in an Elderly Nursing Home but Reduced Transmission and Disease Severity.
Bailly B, Guilpain L, Bouiller K, Chirouze C, N'Debi M, Soulier A, Demontant V, Pawlotsky JM, Rodriguez C, Fourati S. Bailly B, et al. Among authors: fourati s. Clin Infect Dis. 2022 Feb 11;74(3):517-520. doi: 10.1093/cid/ciab446. Clin Infect Dis. 2022. PMID: 33993228 Free PMC article.
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers.
Marot S, Malet I, Leducq V, Abdi B, Teyssou E, Soulie C, Wirden M, Rodriguez C, Fourati S, Pawlotsky JM, Boutolleau D, Burrel S, Calvez V, Marcelin AG, Jary A. Marot S, et al. Among authors: fourati s. Clin Infect Dis. 2022 Mar 1;74(4):707-710. doi: 10.1093/cid/ciab492. Clin Infect Dis. 2022. PMID: 34050731 Free PMC article.
Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral "variants of concern": Implications for clinical use.
Fourati S, Soulier A, Gourgeon A, Khouider S, Langlois C, Galbin A, Bouter AL, Rodriguez C, Joanny M, Dublineau A, Challine D, Bouvier-Alias M, Chevaliez S, Audureau É, Pawlotsky JM. Fourati S, et al. J Clin Virol. 2022 Jan;146:105048. doi: 10.1016/j.jcv.2021.105048. Epub 2021 Nov 29. J Clin Virol. 2022. PMID: 34863056 Free PMC article.
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.
Gaymard A, Bosetti P, Feri A, Destras G, Enouf V, Andronico A, Burrel S, Behillil S, Sauvage C, Bal A, Morfin F, Van Der Werf S, Josset L; ANRS MIE AC43 COVID-19; French viro COVID group; Blanquart F, Coignard B, Cauchemez S, Lina B. Gaymard A, et al. Euro Surveill. 2021 Mar;26(9):2100133. doi: 10.2807/1560-7917.ES.2021.26.9.2100133. Euro Surveill. 2021. PMID: 33663644 Free PMC article.
Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19.
Rodriguez C, de Prost N, Fourati S, Lamoureux C, Gricourt G, N'debi M, Canoui-Poitrine F, Désveaux I, Picard O, Demontant V, Trawinski E, Lepeule R, Surgers L, Vindrios W, Lelièvre JD, Mongardon N, Langeron O, Cohen JL, Mekontso-Dessap A, Woerther PL, Pawlotsky JM. Rodriguez C, et al. Among authors: fourati s. PLoS Pathog. 2021 Mar 29;17(3):e1009416. doi: 10.1371/journal.ppat.1009416. eCollection 2021 Mar. PLoS Pathog. 2021. PMID: 33780519 Free PMC article. Clinical Trial.
217 results